Trial Profile
Clinical Trials Insight: 700044021
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 May 2009
Price :
$35
*
At a glance
- Drugs IMD 1041 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Institute of Medicinal Molecular Design
- 04 May 2009 New trial record.